Pfizer Held To Maturity Securities Noncurrent decreased by 2.1% to $47.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $47.00M to $47.00M. Over 5 years (FY 2020 to FY 2025), Held To Maturity Securities Noncurrent shows an upward trend with a 5.3% CAGR.
non_current_assets_held_to_maturity_securities_noncurrent| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $35.00M | $32.00M | $34.00M | $41.00M | $39.00M | $36.00M | $48.00M | $52.00M | $50.00M | $50.00M | $47.00M | $45.00M | $54.00M | $47.00M | $45.00M | $47.00M | $48.00M | $48.00M | $48.00M | $47.00M |
| QoQ Change | — | -8.6% | +6.3% | +20.6% | -4.9% | -7.7% | +33.3% | +8.3% | -3.8% | +0.0% | -6.0% | -4.3% | +20.0% | -13.0% | -4.3% | +4.4% | +2.1% | +0.0% | +0.0% | -2.1% |
| YoY Change | — | — | — | — | +11.4% | +12.5% | +41.2% | +26.8% | +28.2% | +38.9% | -2.1% | -13.5% | +8.0% | -6.0% | -4.3% | +4.4% | -11.1% | +2.1% | +6.7% | +0.0% |